More than 35 million people in the U.S. have chronic kidney disease (CKD), a condition in which the kidneys are damaged and ...

Kidney disease affects millions of Americans, with Black communities facing disproportionately higher risks due to genetic factors, socioeconomic challenges, ...

This article delves into 15 key warning signs of kidney disease that should not be ignored in the Black community.

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.

In India, the prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with population-based studies ...

Drinking tea may help people with chronic kidney disease (CKD) live longer, according to a study published on January 13 in Renal Failure. The study highlights how tea consumption might lower the risk ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.